Third, even in endometrial cancers in which the mutational frequency of POLE is relatively high, the mutational frequencies of other mutations in the exonuclease domain of POLE are extremely low (i.e., usually <5%) (Supplementary Table S4) [34]. Here, POLE is linked to endometrial cancer.